Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
JOHNSON & JOHNSON
JNJ
Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including...
immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, and vision fields. These products are distributed to wholesalers, hospitals, and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:JNJ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(345)
•••
BSdetector2016
X
View Profile
View Bullboard History
Post by
BSdetector2016
on Apr 05, 2024 12:55pm
Will this ever turn around?
EOM.
(1)
•••
TechTitan
X
View Profile
View Bullboard History
Comment by
TechTitan
on Oct 06, 2023 1:38pm
RE:A BIG DAY for us
looks like like S&P could turn around and help J&J
Addition Of New Copper Claims at Topley Project
posted Apr 19, 2024 9:00am by
Geologica Resource Corp.
-
|
Geologica’s Topley Property is located in British Columbia, a global leader in the development of socially and environmentally responsible resources. Combined with a positive market sentiment for commodities like gold, silver, copper and molybdenum, Topley and Geologica are well-positioned to create significant value for shareholders ...read more
(29)
•••
StockAlchemy
X
View Profile
View Bullboard History
Post by
StockAlchemy
on Jul 20, 2023 10:52am
A BIG DAY for us
Earnings report for us today.
(2010)
•••
scottrose
X
View Profile
View Bullboard History
Post by
scottrose
on Jul 06, 2023 9:36am
Starting slow
Jumped in on this a while back and so far the decision to hold is one I don't regret.
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Apr 13, 2023 3:21am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(319)
•••
jimsenior
X
View Profile
View Bullboard History
Post by
jimsenior
on Jan 23, 2023 9:56am
Aveeno
Until recently Aveeno daily moisturizing lotion was using Canadian oats. They no longer mention Canadian oats on their bottle. I have contacted the company in re this matter. and have not
...more
(0)
•••
robertsmith02
X
View Profile
View Bullboard History
Post by
robertsmith02
on Aug 23, 2022 4:15am
Ophthalmic Lasers Market to Grow at 5.07% CAGR by 2027
The latest research study, "Ophthalmic Lasers Market: Global Industry Trends, Size, Growth, Opportunity and Forecast 2022-2027" has been added by IMARC Group. The global ophthalmic
...more
(1)
•••
edwardebreen15
X
View Profile
View Bullboard History
Post by
edwardebreen15
on Aug 22, 2022 8:45am
Point-of-Care Diagnostics Market Size and Share 2021-2026
According to IMARC Group’s latest report, titled “Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global market reached a strong
...more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Jul 15, 2022 9:00pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Jun 03, 2022 4:24am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
FSD Pharma ready to proceed with Phase 2 clinical trial of
...more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Jun 01, 2022 11:58pm
FSD Pharma Files Investigational New Drug Application “IND”
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on May 11, 2022 12:19am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on May 01, 2022 11:20pm
Lucid-MS for Multiple Sclerosis Treatment
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Apr 24, 2022 1:29am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Apr 17, 2022 6:34am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
The Increasing Investments by the Defense and Military Sectors is Driving the Demand for Helium
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors